免疫检查点抑制剂用于治疗肝细胞癌
Zeynep Akbulut1,2, Başak Aru3, Furkan Aydın3
1Cancer and Stem Cell Research Center, Maltepe University, Istanbul, Türkiye.
Frontiers in immunology
|April 19, 2024
概括
肝细胞癌 (HCC) 治疗正在通过免疫疗法如免疫检查点抑制剂 (ICI) 取得进展. 这些疗法在改善HCC患者的生存率方面表现有前途,为肝癌提供了新的治疗选择.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
背景情况:
- 尽管治疗进展,肝细胞癌 (HCC) 仍然是一个重大的全球健康挑战.
- 在HCC中,瘤微环境 (TME) 通常促进免疫逃避和转移.
- 免疫疗法提供了一种新的方法来利用免疫系统对抗癌症.
研究的目的:
- 审查免疫系统在HCC发育中的作用.
- 总结针对HCC的免疫检查点抑制剂 (ICI) 的临床试验结果.
- 概述ICI在HCC治疗中使用的挑战和考虑因素.
主要方法:
- 关于HCC和癌症免疫治疗的文献综述.
- 对HCC治疗中ICI的临床试验数据的分析.
- 讨论涉及ICI的组合疗法.
主要成果:
- 免疫疗法,特别是ICI,在改善HCC患者的一个子集的存活率方面表现出有效性.
- 组合疗法 (ICI与抗血管原剂或TKI) 延长了晚期HCC的存活时间.
- 对于在一线治疗中进展的患者来说,ICI提供了替代治疗选择.
结论:
- 免疫疗法代表了HCC治疗的重大进展.
- 单独或组合的ICI对于管理HCC至关重要.
- 需要进一步的研究和仔细考虑,以在HCC中进行最佳的ICI管理.
更多相关视频
07:32Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis
Published on: April 12, 2024
1.3K
11:08Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells
Published on: February 14, 2025
744
相关概念视频
01:27Tumor Immunotherapy
522
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
522
02:34Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K